Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial
相（物质）
肥胖
医学
内科学
化学
有机化学
作者
Ania M. Jastreboff,Donna H. Ryan,Harold Bays,Peter R. Ebeling,Mia Mackowski,Nisha Philipose,Leorah Ross,Yimeng Liu,Catherine M. Burns,Siddique Abbasi,Nicola Pannacciulli
In this phase 2 trial, once-monthly maridebart cafraglutide resulted in substantial weight reduction in participants with obesity with or without type 2 diabetes. (Funded by Amgen; ClinicalTrials.gov number, NCT05669599.).
PDF的下载单位、IP信息已删除
BowieHuang
无极微光
Zx_1993
ceeray23
pluto
子车茗
Stella
不配.
邓佳鑫Alan
buno
残剑月
Criminology34
yznfly
LYW
蓝天
djshao
niNe3YUE
香蕉诗蕊
李李李
Dali
夜琉璃
黑猫乾杯
tuanheqi
freyaaaaa
皖公网安备34019202002308
